Motley Fool: 5 Top Pharmaceutical Stocks to Buy in 2019

More than $320 billion was spent on prescription drugs in the U.S. in 2016, a figure that’s expected to nearly double to $610 billion by 2021, according to IQVIA (formerly QuintilesIMS). With so much money being spent on necessary medicines,…

Advertisements

Motley Fool: 2 Healthcare Stocks Ripe for a Takeover

The healthcare sector has a well-earned reputation for ultra-pricey acquisitions. In 2017, for example, Gilead Sciences paid nearly $12 billion for Kite Pharma and its commercially unproven cell therapy platform. Kicking off this year, Bristol-Myers Squibb struck a $74 billion deal to…

Motley Fool: Stock Market Power Rankings: Apple Jacks

Each week, I’m ranking the biggest companies that trade on U.S. exchanges based on their size (market capitalization), momentum (total return over the past year), and recent news. Before we get to the rankings, a quick word on a major player.…

Motley Fool: Here Are the 2019 Dogs of the Dow

For most investors, the simpler their investment strategy, the better. Even the most conservative investors can feel comfortable investing in the stocks included in the Dow Jones Industrial Average (DJINDICES:^DJI), so using this basket of 30 stocks to guide your…

Motley Fool: 3 Stocks to Build Your Portfolio Around

Just 86 stocks accounted for half of the increase in the U.S. stock market between 1926 and 2016, according to a paper by Professor Hendrik Bessembinder of Arizona State University. His research further shows that only 4% of all stocks…